BiotechTube
Home/Spirair/James Kintzing, PhD
JK

James Kintzing, PhD

Co-founder & Chief Technology Officer

Spirair

Therapeutic Areas

RespiratoryOtolaryngology

Spirair Pipeline

DrugIndicationPhase
SeptAlignMinor Nasal Septal Deviation (NSD)Approved
TurbAlignTurbinate Hypertrophy/MedializationPre-commercial

Leadership Team at Spirair

BB
Ben Bishop
Chief Executive Officer
BM
Brandon McCutcheon, MD
Co-founder & Chief Medical Officer
PP
Paul Praino
VP of Sales
TH
Tracey Henry
Vice President, Clinical, Quality & Regulatory
AU
Andy Uchida
Executive Vice President, R&D and Operations
View full Spirair profile